Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187180 · ClinicalTrials.gov registry record · NA
Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate
A NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms, sponsored by Smita De.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07187180 is a NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms that is actively recruiting participants, run by Smita De. The registered enrollment target is 50 participants, below the 737-participant average among 3 other BPH With Urinary Obstruction trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07187180, a NA study of BPH With Urinary Obstruction and BPH With Symptomatic Lower Urinary Tract Symptoms, is actively recruiting participants, sponsored by Smita De.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enucleation and is recommended by the American Urological Association (AUA), along with thulium laser enucleation of the prostate (ThuLEP), as size-independent techniques for the management of BPH with fewer complications than transurethral resection of the prostate (TURP). Further development of laser technology has additionally led to enucleation using pulsed-modulated (e.g. "Virtual Basket™" mode or MOSES™ mode) holmium lasers as well as the thulium fiber laser.
Conditions Studied
Interventions
- DEVICE holmium laser
- DEVICE pulsed thulium laser
Study Locations (1)
Ohio
- Cleveland Clinic Main - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-06-02 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07187180
The ClinicalTrials.gov registry entry for NCT07187180 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 737-participant average among 3 other BPH With Urinary Obstruction trials with a reported enrollment target (93% lower). The listed sponsor is Smita De, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with BPH With Urinary Obstruction appearing as the primary indexed condition, and to 2 interventions - of which holmium laser is the first listed.
NCT07187180 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07187180 about?
NCT07187180 is a clinical study titled "Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate". Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enuc...
What is the current status of trial NCT07187180?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-06-02. Estimated completion is 2026-09.
What conditions does trial NCT07187180 study?
This clinical trial studies the following conditions: BPH With Urinary Obstruction, BPH With Symptomatic Lower Urinary Tract Symptoms.
What interventions are being tested in trial NCT07187180?
The interventions under investigation include: holmium laser (DEVICE), pulsed thulium laser (DEVICE).
Who is sponsoring clinical trial NCT07187180?
This trial is sponsored by Smita De, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07187180 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for BPH With Urinary Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
BPH With Urinary Obstruction
All registered trials for this condition
BPH With Symptomatic Lower Urinary Tract Symptoms
All registered trials for this condition
Ohio
All trials with a study site in Ohio
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.